Blood Screening Test for Alzheimer’s disease

Antibody

Development of a diagnostic screening test for the detection and differentiation of Alzheimer's disease in humans. 

 

Development of an enrichment process for diagnostically relevant tau protein in blood samples from patients.

 

Improvement of the detection limit of immunological test methods for Alzheimer's related biomarkers. 

Joint Project

Roboscreen GmbH, Paul-Flechsig-Institute and Leipzig Medical Biobank (LIFE) of Leipzig University develop and evaluate enrichment methods as well as improvement of biomarker detection and quantification of Alzheimer's related biomarkers in blood/serum/plasma and urine.

Funded Project (100550551)

Supported by funding from the European Union and the Free State of Saxony from ERDF funds.

Timeline

Started in December 2021.

This site uses cookies

This site uses cookies. These have two functions: First, they provide basic functionality for this website. Second, they enable us to improve our content for you by storing and analyzing anonymous user data. You can withdraw your consent to the use of these cookies at any time. More information about cookies can be found in our privacy policy.

More information
+
Essential

Essential cookies are required for basic functions of the website. This ensures that the website functions properly.

Name QiCookieConsent
Provider QiTEC GmbH
Purpose Contains the cookie groups approved by the user and checks them when the page is accessed.
Lifetime 1 year